PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

R.R. Wildeboer, R.J.G. van Sloun, P. Huang, H. Wijkstra, M. Mischi (Corresponding author)

Research output: Contribution to journalConference articleAcademicpeer-review

Abstract

Introduction & Objectives: A non-targeted 12-core systematic biopsy (SBx) procedure guided by transrectal ultrasound (TRUS) is currently guideline-recommended for prostate cancer (PCa) diagnosis. Despite the risk of complications, underdiagnosis, and overtreatment associated with SBx, until now image-based targeted biopsy has not proven sufficiently accurate to replace SBx. Three-dimensional (3D) dynamic contrastenhanced ultrasound (DCE-US) was recently introduced for prostate imaging, permitting to image the entire gland with a single bolus injection. Quantitative two-dimensional DCE-US has already shown promising for PCa localization. Here, we present a new method for PCa localization by multiparametric analysis of 3D DCE-US.
Original languageEnglish
Pages (from-to)e1870-e1871
Number of pages2
JournalEuropean Urology Supplements
Volume18
Issue number1
DOIs
Publication statusPublished - 2019
Event34th Annual EAU Congress European Association of Urology (EAU19) - Fira Gran Via, Barcelona, Spain
Duration: 15 Mar 201919 Mar 2019
https://eaucongress.uroweb.org/

Bibliographical note

Abstracts EAU19 – 34th Annual EAU Congress

Fingerprint Dive into the research topics of 'PT150 - 3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy'. Together they form a unique fingerprint.

  • Cite this